Author Archives: Jan Paschal

Upsized twice today: BioAge Labs (BIOA) increased its IPO’s size at pricing – to 11.0 million shares – up from 10.5 million – and priced its IPO at $18.00 – the mid-point of its range – to raise $198 million on Wednesday night, Sept. 25, 2024. The pricing news marked the second time today that […]

BKV Corp. (BKV), a natural gas fracking company, priced its IPO at $18.00 – $1.00 below the bottom of its price range – and sold 15 million shares – to raise $270 million after the closing bell on Wednesday, Sept. 25, 2024. The proceeds were $30 million less than if the IPO had been priced at […]

BioAge Labs (BIOA Proposed), a Phase II biotech developing an anti-obesity drug, upsized its IPO early today by increasing the number of shares to 10.5 million – up from 7.5 million originally – according to an S-1/A filing dated Sept. 25, 2024. That’s a 40 percent increase. BioAge Labs now expects to raise $189 million – […]

Just as the sun rose over Wall Street today, StandardAero (SARO Proposed) unveiled the terms for its $1 billion IPO. StandardAero is offering 46.5 million shares at a price range of $20.00 to $23.00 to raise $999.75 million – essentially $1 billion – in its initial public offering, according to its S-1/A filing, dated Sept. […]

Global Engine Group Holding Ltd.  (GLE) trimmed its small IPO to 2.0 million shares – down from 2.5 million shares – and priced the IPO at $4.00 – the low end of its $4.00-to-$5.00 range – to raise $8.0 million on Thursday night, Sept. 19, 2024. Global Engine Group’s stock opened at $5.15 – up $1.15 – at 12:25 […]

Cayson Acquisition (CAPNU) priced its small IPO – 6.0 million units at $10.00 each – to raise $60.0 million, as expected, on Thursday night, Sept. 19, 2024. The New York-based SPAC intends to focus its search for target businesses throughout Asia, the prospectus said. Cayson Acquisition is the second SPAC IPO priced this week and […]

Upstream Bio (UPB Proposed), a Phase 2 clinical biotech focused on severe respiratory disease, filed plans to raise up to $100 million in an IPO, according to its S-1 filing on Wednesday, Sept. 18, 2024. Upstream Bio said it intends to list its stock on the NASDAQ. Upstream Bio’s S-1 filing was disclosed late Wednesday […]

BioAge Labs Inc. (BIOA Proposed) unveiled the terms for its IPO today – Wednesday, Sept. 18, 2024 – on the same day that the Federal Reserve cut interest rates by 50 basis points – the first U.S. interest-rate cut in four years. BioAge is offering 7.5 million shares at a price range of $17.00 to $19.00 […]

Yuanbao Inc. (YB Proposed) – the largest independent insurance distributor in China’s personal life and A&H (accident and health) insurance market in terms of first-year premiums in 2023, according to Frost & Sullivan – filed plans for its U.S. IPO today – Tuesday, Sept. 17, 2024. The Beijing-based insurance holding company did not disclose its […]

Guardian Pharmacy Services (GRDN Proposed) unveiled the terms for its $101.3 million IPO today – Monday, Sept. 16, 2024 – and launched the deal for pricing next week. The Atlanta-based pharmacy services company is offering 6.75 million shares at a price range of $14.00 to $16.00 to raise $101.25 million, if priced at the $15.00 […]